Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Pacira reported $542.92M in Loan Capital for its fiscal quarter ending in March of 2023.

Loan Capital Change
AmerisourceBergen ABC:US USD 4.67B 10.5M
Astellas Pharma 4503:JP JPY 139.92B 8.81B
Endo International ENDP:US USD 7.69B 7.69B
Horizon Pharma HZNP:US USD 2.54B 2.61M
Ironwood Pharmaceuticals IRWD:US USD 396.65M 402K
J&J JNJ:US USD 34.93B 8.04B
Pacira PCRX:US USD 542.92M 112.9M
Perrigo PRGO:US USD 4.06B 7.6M
Revance Therapeutics RVNC:US USD 379.86M 485K
Teva Pharmaceutical Industries Ltd TEVA:IT USD 19.67B 565M
Zoetis ZTS:US USD 6.56B 7M